Psych Symposium

MindMed’s Phase 2 LSD Trial Treating Anxiety Was a Success
May 11, 2022June 2, 2024 Business, Learn, News, Research

Researchers at PSYCH Symposium reveal promising results from double-blind, placebo-controlled study with 46 patients.
Why Wednesday Will Be Biggest Day of 2022 for Psychedelic Investors
May 10, 2022June 2, 2024 Business, Editorial, Learn

Psychedelic investors are about to see pivotal data presented on flagship programs by the titans of the psychedelics industry.

MindMed’s Phase 2 LSD Trial Treating Anxiety Was a Success